Site-specific drug delivery systems within the gastro-intestinal tract: From the mouth to the colon

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 44-52

  Pinto, João F ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Colon; Mouth; Oesophagus; Oral drug delivery; Small intestine; Stomach

Indexed keywords

ACICLOVIR; BENZOCAINE; CANNABIDIOL; CAPTOPRIL; CARBOMER; CARVEDILOL; CHITOSAN; CHLORHEXIDINE ACETATE; CLOTRIMAZOLE; CYCLODEXTRIN; ECONAZOLE; FENTANYL; FLUOROURACIL; GLYCERYL TRINITRATE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; KETOPROFEN; LANSOPRAZOLE; LIDOCAINE; METRONIDAZOLE; MICONAZOLE; NICOTINE TARTRATE; RANITIDINE; RIBOFLAVIN; SALBUTAMOL SULFATE; SUMATRIPTAN SUCCINATE; THIOCOLCHICOSIDE; TRAMADOL; UNINDEXED DRUG; VERAPAMIL; DRUG CARRIER; DRUG DOSAGE FORM;

ADHESION; CHEMICAL MODIFICATION; CHEWABLE TABLET; CHEWING GUM; COLON MOTILITY; DELAYED DRUG RELEASE; DENSITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; EFFERVESCENT TABLET; ESOPHAGUS MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE MOTILITY; PH; PRIORITY JOURNAL; REVIEW; STOMACH MOTILITY; SUSTAINED DRUG RELEASE; SWALLOWING; TABLET DISINTEGRATION TIME; TABLET POROSITY; COLON; DRUG DOSAGE FORM; DRUG FORMULATION; ESOPHAGUS; MEDICINAL CHEMISTRY; MOUTH; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SMALL INTESTINE; STOMACH;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; COLON; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; ESOPHAGUS; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINE, SMALL; MOUTH; STOMACH;

EID: 77954314100     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.05.003     Document Type: Review

References (108)

1. Abu-Huwaij R., Assaf S., Salem M., Sallam A. Mucoadhesive dosage form of lidocaine hydrochloride: I. mucoadhesive and physicochemical characterization. Drug Dev. Ind. Pharm. 2007, 33:855-864.
2. Ahrabi S.F., Madsen G., Dyrstad K., Sande S.A., Graffner C. Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. 12th Annual Meeting of the AAPS 1997.
3. Alanazi F.K., Rahman A.A.A., Mahrous G.M., Alsarra I.A. Formulation and physicochemical characterisation of buccoadhesive films containing ketorolac. J. Drug Del. Sci. Technol. 2007, 17:183-192.
4. Ali J., Khar R.K., Ahuja A. Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions. Pharmazie 1998, 53:329-334.
5. Alur H.H., Beal J.D., Pather S.I., Mitra A.K., Johnston T.P. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci. 1999, 88:1313-1319.
6. Alur H.H., Desai R.P., Mitra A.K., Johnston T.P. Inhibition of a model protease - pyroglutamate aminopeptidase by a natural oligosaccharide gum from Hakea gibbosa. Int. J. Pharm. 2001, 212:171-176.
7. Ameye D., Mus D., Foreman P., Remon J.P. Spray-dried Amioca (R) starch/Carbopol (R) 974P mixtures as buccal bioadhesive carriers. Int. J. Pharm. 2005, 301:170-180.
8. Anlar S., Capan Y., Guven O., Gogus A., Dalkara T., Hincal A.A. Formulation and in-vitro in-vivo evaluation of buccoadhesive morphine-sulphate tablets. Pharm. Res. 1994, 11:231-236.
9. Artusi M., Santi P., Colombo P., Junginger H.E. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int. J. Pharm. 2003, 250:203-213.
10. Asghar L.F.A., Chandran S. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J. Pharm. Pharm. Sci. 2006, 9:327-338.
11. Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J. Control. Rel. 1993, 26:213-220.
12. Ashford M., Fell J.T. Targeting drugs to the colon-delivery systems for oral-administration. J. Drug Target. 1994, 2:241-257.
13. Attia M.A., El-Gibaly I., Shaltout S.E., Fetih G.N. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int. J. Pharm. 2004, 276:11-28.
14. Atyabi F., Majzoob S., Dorkoosh F., Sayyah M., Ponchel G. The impact of trimethyl chitosan on in vitro mucoadhesive properties of pectinate beads along different sections of gastrointestinal tract. Drug Dev. Ind. Pharm. 2007, 33:291-300.
15. Averineni R.K., Sunderajan S.G., Mutalik S., Nayak U., Shavi G., Armugam K., Meka S.R., Pandey S., Nayanabhirama U. Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study. Pharm. Dev. Technol. 2009, 14:199-207.
16. Awad G.A.S., Charrueau C.A.A., Allain P., Chaumeil J.C. Formulation and evaluation of bioadhesive pellets containing different carbomers made by extrusion-spheronization. STP Pharm. Sci. 2002, 12:157-162.
17. Baldi F., Malfertheiner P. Lansoprazole fast disintegrating tablet: A new formulation for an established proton pump inhibitor. Digestion 2003, 67:1-5.
18. Barrow L., Spiller R.C., Wilson C.G. Pathological influences on colonic motility-implications for drug delivery. Adv. Drug Del. Rev. 1991, 7:201-218.
19. Basit A.W. Advances in colonic drug delivery. Drugs 2005, 65:1991-2007.
20. Batchelor H. Bioadhesive dosage forms for esophageal drug delivery. Pharm. Res. 2005, 22:175-181.
21. Batchelor H.K., Tang M., Dettmar P.W., Hampson F.C., Jolliffe I.G., Craig D.Q.M. Feasibility of a bioadhesive drug delivery system targeted to oesophageal tissue. Eur. J. Pharm. Biopharm. 2004, 57:295-298.
22. Baumgartner S., Kristl J., Vrecer F., Vodopivec P., Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000, 195:125-135.
23. Baumgartner S., Smid-Korbar J., Vrecer F., Kristl J. Physical and technological parameters influencing floating properties of matrix tablets based on cellulose ethers. STP Pharm. Sci. 1998, 8:285-290.
24. Bernkop-Schnurch A., Konig V., Leitner V.M., Krauland A.H., Brodnik I. Preparation and characterisation of thiolated poly(methacrylic acid)-starch compositions. Eur. J. Pharm. Biopharm. 2004, 57:219-224.
25. Bies C., Lehr C.M., Woodley J.F. Lectin-mediated drug targeting: history and applications. Adv. Drug Del. Rev. 2004, 56:425-435.
26. Blancofuente H., Anguianoigea S., Oteroespinar F.J., Blancomendez J. In-vitro bioadhesion of carbopol hydrogels. Int. J. Pharm. 1996, 142:169-174.
27. Blick S.K.A., Wagstaff A.J. Fentanyl buccal tablet-in breakthrough pain in opioid-tolerant patients with cancer. Drugs 2006, 66:2387-2393.
28. Bouckaert S., Remon J.P. In-vitro bioadhesion of a buccal, miconazole slow-release tablet. J. Pharm. Pharmacol. 1993, 45:504-507.
29. Burgalassi S., Panichi L., Saettone M.F., Jacobsen J., Rassing M.R. Development and in vitro in vivo testing of mucoadhesive buccal patches releasing benzydamine and lidocaine. Int. J. Pharm. 1996, 133:1-7.
30. Bussemer T., Otto I., Bodmeier R. Pulsatile drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2001, 18:433-458.
31. Cappello B., de Rosa G., Giannini L., la Rotonda M.I., Mensitieri G., Miro A., Quaglia F., Russo R. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system. Int. J. Pharm. 2006, 319:63-70.
32. Carelli V., di Colo G., Nannipieri E., Poli B., Serafini M.F. Polyoxyethylene-poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral delivery. Int. J. Pharm. 2000, 202:103-112.
33. Chen J., Blevins W.E., Park H., Park K. Gastric retention properties of superporous hydrogel composites. J. Control. Rel. 2000, 64:39-51.
34. Chen J., Park H., Park K. Synthesis of superporous hydrogels: Hydrogels with fast swelling and superabsorbent properties. J. Biomed. Mater. Res. 1999, 44:53-62.
35. Chen J., Park K. Synthesis of fast-swelling, superporous sucrose hydrogels. Carbohydr. Polym. 2000, 41:259-268.
36. Chourasia M.K., Jain S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 2003, 6:33-66.
37. Chourasia M.K., Jain S.K. Polysaccharides for colon targeted drug delivery. Drug Del. 2004, 11:129-148.
38. Chueh H.R., Zia H., Rhodes C.T. Optimization of sotalol floating and bioadhesive extended-release tablet formulations. Drug Dev. Ind. Pharm. 1995, 21:1725-1747.
39. Chun M.K., Kwalk B.T., Choi H.K. Preparation of buccal patch composed of carbopol, poloxamer and hydroxypropyl methylcellulose. Arch. Pharm. Res. 2003, 26:973-978.
40. Desai S., Bolton S. A floating controlled-release drug-delivery system-in-vitro in-vivo evaluation. Pharm. Res. 1993, 10:1321-1325.
41. Deshpande A.A., Shah N.H., Rhodes C.T., Malick W. Development of a novel controlled-release system for gastric retention. Pharm. Res. 1997, 14:815-819.
42. Dhaliwal S., Jain S., Singh H.P., Tiwary A.K. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: In vitro and in vivo evaluation. AAPS J. 2008, 10:322-330.
43. Dhiman M., Yedurkar P., Sawant K.K. Formulation, characterization, and in vitro evaluation of bioadhesive gels containing 5-fluorouracil. Pharm. Dev. Technol. 2008, 13:15-25.
44. Eaimtrakarn S., Prasad Y.V.R., Puthli S.P., Yoshikawa Y., Shibata N., Takada K. Possibility of a patch system as a new oral delivery system. Int. J. Pharm. 2003, 250:111-117.
45. Elkheshen S.A., Yassin A.E.B., Alsuwayeh S., Alkhaled F.A. In vitro and in vivo evaluation of floating controlled release dosage forms of verapamil hydrochloride. Pharmazeutische Ind. 2004, 66:1364-1372.
46. Fedorak R.N., Bistritz L. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv. Drug Del. Rev. 2005, 57:303-316.
47. Gangadharappa H.V., Pramod K.T.M., Shiva K.H.G. Gastric floating drug delivery systems: a review. Indian J. Pharm. Ed. Res. 2007, 41:295-305.
48. Garg S., Kumar G. Development and evaluation of a buccal bioadhesive system for smoking cessation therapy. Pharmazie 2007, 62:266-272.
49. Gazzaniga A., Busetti C., Moro l., Sangalli M.E., Giordano F. Time-dependent oral delivery systems for colon targeting. STP Pharm. Sci. 1995, 5:83-88.
50. Gazzaniga A., Iamartino P., Maffione G., Sangalli M.E. Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 1994, 108:77-83.
51. Gazzaniga A., Palugan L., Foppoli A., Sangalli M.E. Oral pulsatile delivery systems based on swellable hydrophilic polymers. Eur. J. Pharm. Biopharm. 2008, 68:11-18.
52. Giunchedi P., Juliano C., Gavini E., Cossu M., Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm. 2002, 53:233-239.
53. Goswami T., Jasti B., Li X.L. Sublingual drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 2008, 25:449-484.
54. Goto T., Morishita M., Kavimandan N.J., Takayama K., Peppas N.A. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J. Pharm. Sci. 2006, 95:462-469.
55. Groning R., Cloer C., Muller R.S. Development and in vitro evaluation of expandable gastroretentive dosage forms based on compressed collagen sponges. Pharmazie 2006, 61:608-612.
56. Gu T.H., Chen S.X., Zhu J.B., Song D.J., Guo J.Z., Hou H.M. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Acta Pharmacol. Sin. 1992, 13:527-531.
57. Guo J.H. Bioadhesive polymer buccal patches for buprenorphine controlled delivery - formulation, in-vitro adhesion and release properties. Drug Dev. Ind. Pharm. 1994, 20:2809-2821.
58. Guo J.H., Cooklock K.M. The effects of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. J. Pharm. Pharmacol. 1996, 48:255-257.
59. Hinderling P.H., Karara A.H., Tao B., Pawula M., Wilding I., Lu M. Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract. J. Clin. Pharmacol. 2007, 47:19-25.
60. Huang Y., Zheng L.L., Liu J., Zhang Z.R. Synthesis and characterization of HPMC derivatives as novel duodenum-specific coating agents. Arch. Pharmacal Res. 2005, 28:364-369.
61. Hwang S.J., Park H., Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 1998, 15:243-284.
62. Jacobsen J., Bjerregaard S., Pedersen M. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity - drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur. J. Pharm. Biopharm. 1999, 48:217-224.
63. Jain A., Gupta Y., Jain S.K. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J. Pharm. Pharm. Sci. 2007, 10:86-128.
64. Jain S.K., Jain A. Target-specific drug release to the colon. Exp. Opin. Drug Del. 2008, 5:483-498.
65. Jothi M.V., Bhat K.M., Pratibha P.K., Bhat G.S. The evaluation of a biodegradable dental chip containing chlorhexidine in chitosan base as a targeted drug delivery in the management of chronic periodontitis in patients. Drug Dev. Res. 2009, 70:395-401.
66. Juliano C., Cossu M., Pigozzi P., Rassu Gg., Giunchedi P. Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine. AAPS PharmSciTech 2008, 9:1153-1158.
67. Kawashima Y., Niwa T., Takeuchi H., Hino T., Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 1992, 81:135-140.
68. Khanna R., Agarwal S.P., Ahuja A. Preparation and evaluation of bioerodible buccal tablets containing clotrimazole. Int. J. Pharm. 1996, 138:67-73.
69. Klausner E.A., Lavy E., Friedman M., Hoffman A. Expandable gastroretentive dosage forms. J. Control. Rel. 2003, 90:143-162.
70. Krogel I., Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. 1999, 187:175-184.
71. Kumar P., Singh S., Mishra B. Colon targeted delivery systems of metronidazole based on osmotic technology: development and evaluation. Chem. Pharm. Bull. 2008, 56:1234-1242.
72. Lee J.S., Jung Y.J., Doh M.J., Kim Y.M. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Dev. Ind. Pharm. 2001, 27:331-336.
73. Lele B.S., Hoffman A.S. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J. Control. Rel. 2000, 69:237-248.
74. Li C., Bhatt P.P., Johnston T.P. Evaluation of a mucoadhesive buccal patch for delivery of peptides: In vitro screening of bioadhesion. Drug Dev. Ind. Pharm. 1998, 24:919-926.
75. Liang, A.C., Chen, L.I.H., 2001. Fast-dissolving intraoral drug delivery systems. Exp. Opin. Ther. Patents, 11, 981-986.
76. Lin S.Y., Lin P.C. Effect of acid type, acetic-acid and sodium carboxymethyl cellulose concentrations on the formation, micromeritic, dissolution and floating properties of theophylline chitosan microcapsules. Chem. Pharm. Bull. 1992, 40:2491-2497.
77. Maffei P., Borgia S.L., Sforzini A., Yasin A., Ronchi C., Ceschel G.C. Design and in vitro-in vivo evaluation of a bi-layered tablet containing benzocaine for local buccal administration. J. Drug Del. Sci. Technol. 2004, 14:363-372.
78. Maggi L., Segale L., Conti S., Machiste E.O., Salini A., Conte U. Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. Eur. J. Pharm. Sci. 2005, 24:487-493.
79. Mannila J., Jarvinen T., Jarvinen K., Jarho P. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol. J. Pharm. Sci. 2007, 96:312-319.
80. Mashru R.C., Sutariya V.B., Sankalia M.G., Parikh P.P. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev. Ind. Pharm. 2005, 31:25-34.
81. Mcconnell E.L., Short M.D., Basit A.W. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J. Control. Rel. 2008, 130:154-160.
82. Mcconville J.T., Ross A.C., Florence A.J., Stevens H.N.E. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device. Drug Dev. Ind. Pharm. 2005, 31:79-89.
83. Meka l., Kesavan B., Kalamata V.N., Eaga C.M., Bandari S., Vobalaboina V., Yamsani M.R. Design and evaluation of polymeric coated minitablets as multiple unit gastroretentive floating drug delivery systems for furosemide. J. Pharm. Sci. 2009, 98:2122-2132.
84. Messina J., Darwish M., Fine P.G. Fentanyl buccal tablet. Drugs Today 2008, 44:41-54.
85. Milojevic S., Newton J.M., Cummings J.H., Gibson G.R., Botham R.L., Ring S.G., Stockham M., Allwood M.C. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J. Control. Rel. 1996, 38:85-94.
86. Minghetti P., Colombo A., Montanari L., Gaeta G.M., Gombos F. Buccoadhesive slow-release tablets of acitretin: design and 'in vivo' evaluation. Int. J. Pharm. 1998, 169:195-202.
87. Nagano H., Machida Y., Iwata M., Imada T., Noguchi Y., Matsumoto A., Nagai T. Preparation of magnetic granules containing bleomycin and its evaluation using model esophageal cancer. Int. J. Pharm. 1997, 147:119-125.
88. Overholt B.F., Panjehpour M., deNovo R.C., Peterson M.G., Jenkins C. Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size. Lasers Surg. Med. 1996, 18:248-252.
89. Owens T.S., Dansereau R.J., Sakr A. Development and evaluation of extended release bioadhesive sodium fluoride tablets. Int. J. Pharm. 2005, 288:109-122.
90. Perioli l., Ambrogi A., Angelici F., Ricci M., Giovagnoli S., Capuccella M., Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. J. Control. Rel. 2004, 99:73-82.
91. Pithavala Y.K., Heizer W.D., Parr A.F., OóCconnor-Semmes R.L., Brouwer K.L.R. Use of the InteliSite (R) capsule to study ranitidine absorption from various sites within the human intestinal tract. Pharm. Res. 1998, 15:1869-1875.
92. Repka M.A., Prodduturi S., Stodghill S.P. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev. Ind. Pharm. 2003, 29:757-765.
93. Sakr F.M. A programmable drug delivery system for oral administration. Int. J. Pharm. 1999, 184:131-139.
94. Sawicki W. Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. Eur. J. Pharm. Biopharm. 2002, 53:29-35.
95. Schellekens R.C.A., Stellaard F., Mitrovic D., Stuurman F.E., Kosterink J.G.W., Frijlink H.W. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. J. Control. Rel. 2008, 132:91-98.
96. Scholz O.A., Wolff A., Schumacher A., Giannola l., Campisi I., Ciach G., Velten T.T. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discov. Today 2008, 13:247-253.
97. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. British Pharmaceutical Conference 1998.
98. Segale L., Maggi L., Machiste E.O., Conti S., Conte U., Grenier A., Besse C. Formulation design and development to produce orodispersible tablets by direct compression. J. Drug Del. Sci. Technol. 2007, 17:199-203.
99. Shidhaye S.S., Saindane N.S., Sutar S., Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate. AAPS PharmSciTech 2008, 9:909-916.
100. Siepmann F., Siepmann J., Walther M., Macrae R.J., Bodmeier R. Polymer blends for controlled release coatings. J. Control. Rel. 2008, 125:1-15.
101. Siew L.F., Man S.M., Newton J.M., Basit A.W. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Int. J. Pharm. 2004, 273:129-134.
102. Steingoetter A., Weishaupt D., Kunz P., Mader K., Lengsfeld H., Thumshirn M., Boesiger P., Fried M., Schwizer W. Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets. Pharm. Res. 2003, 20:2001-2007.
103. Streubel A., Siepmann J., Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 2003, 18:37-45.
104. Tagarro I., Vauzelle-Kervroedan F., Diez M.C. Pharmacokinetic assessment of a fast-release orodispersible tramadol tablet compared to a conventional tramadol capsule. Arzneimittel-Forschung-Drug Res. 2004, 54:293-297.
105. Vandamme T.F., Lenourry A., Charrueau C., Chaumeil J. The use of polysaccharides to target drugs to the colon. Carbohydr. Pol. 2002, 48:219-231.
106. Yang L.B., Chu J.S., Fix J.A. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm. 2002, 235:1-15.
107. Zhang l., Russell D., Conway B.R., Batchelor H. Strategies and therapeutic opportunities for the delivery of drugs to the esophagus. Crit. Rev. Ther. Drug Carrier Syst. 2008, 25:259-304.
108. Zou H., Jiang X.T., Kong L.S., Gao S. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release. J. Pharm. Sci. 2008, 97:263-273.